BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome.

Takotsubo Syndrome Clinical Trial

Official title:
BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome. A Multinational, Multicentre, Registry-based, Open-label, Randomized Controlled Trial.

Status Recruiting

Clinical Trial Summary

The aim of this study is to document an optimized pharmacologic treatment for patients with Takotsubo Syndrome. There is currently no published documentation in a large number of patients. The study is a Randomized Registry Clinical Trial and in total 1000 patients registered in SWEDEHEART will be included.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04666454
Study type	Interventional
Source	Vastra Gotaland Region
Contact	Elmir Omerovic, MD PhD
Phone	31 3421000
Email	elmir@wlab.gu.se
Status	Recruiting
Phase	Phase 4
Start date	December 14, 2020
Completion date	December 2028

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03726528` - Optimized Characterization of Takotsubo Syndrome by Obtaining Pressure Volume Loops	N/A
Recruiting	`NCT03324529` - Autonomic Modulation in Takotsubo Syndrome	N/A
Recruiting	`NCT04634487` - Polish Registry of Takotsubo Syndrome
Completed	`NCT01249599` - Stress-induced Vascular Dysfunction: Evaluation of Endothelial Function in a Cohort of Patients With Takotsubo Syndrome	N/A
Recruiting	`NCT05731830` - Takotsubo Syndrome and Air Pollution
Completed	`NCT03801694` - Predicting the Development of Myocardial Depression in Acute Neurological Patients
Terminated	`NCT02867878` - Adenosin to Rapidly Reverse Left Ventricle Impairment in Takotsubo Syndrome	Phase 2
Recruiting	`NCT04361994` - The GErman Italian Spanish Takotsubo (GEIST) Registry